Cheng-Hsun Chiu

Dr. Cheng-Hsun Chiu

Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2013 in Genome Biology
Verified
Journal Article
Open access
PDF file
MCMichael Clarke
Michael Clarke
ALAmanda J Lohan
Amanda J Lohan
BLBernard Liu
Bernard Liu
ILIlias Lagkouvardos
Ilias Lagkouvardos
SRScott Roy
Scott Roy
Brendan LoftusBrendan Loftus
Brendan Loftus
Background: The Amoebozoa constitute one of the primary divisions of eukaryotes, encompassing taxa of both biomedical and evolutionary importance, yet its genomic diversity remains largely unsampled. Here we present an analysis of a whole genome assembly of Acanthamoeba castellanii (Ac) the first representative from a solitary free-living amoebozoan. Results: Ac encodes 15,455 compact intron-rich genes, a significant number of which are predicted to have arisen through inter-kingdom lateral gene transfer (LGT). A majority of the LGT candidates have undergone a substantial degree of intronization and Ac appears to have incorporated them into established transcriptional programs. Ac manifests a complex signaling and cell communication repertoire, including a complete tyrosine kinase signaling toolkit and a comparable diversity of predicted extracellular receptors to that found in the facultatively multicellular dictyostelids. An important environmental host of a diverse range of bacteria and viruses, Ac utilizes a diverse repertoire of predicted pattern recognition receptors, many with predicted orthologous functions in the innate immune systems of higher organisms. Conclusions: Our analysis highlights the important role of LGT in the biology of Ac and in the diversification of microbial eukaryotes. The early evolution of a key signaling facility implicated in the evolution of metazoan multicellularity strongly argues for its emergence early in the Unikont lineage. Overall, the availability of an Ac genome should aid in deciphering the biology of the Amoebozoa and facilitate functional genomic studies in this important model organism and environmental host.

1 March 2020 in Journal of the Formosan Medical Association
Verified
Journal Article
Open access
QCQing Cao
Qing Cao
YCYi-Ching Chen
Yi-Ching Chen
CCChyi-Liang Chen
Chyi-Liang Chen
Cheng-Hsun ChiuCheng-Hsun Chiu
Cheng-Hsun Chiu

15 August 2004 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
LSLin-Hui Su
Lin-Hui Su
Cheng-Hsun ChiuCheng-Hsun Chiu
Cheng-Hsun Chiu
CCChishih Chu
Chishih Chu
JOJonathan T. Ou
Jonathan T. Ou
Increasing antimicrobial resistance in nontyphoid Salmonella species has been a serious problem for public health worldwide. The high rate of resista

1 April 2004 in Clinical Microbiology Reviews
Verified
Journal Article
Open access
PDF file
Cheng-Hsun ChiuCheng-Hsun Chiu
Cheng-Hsun Chiu
LSLin-Hui Su
Lin-Hui Su
CCChishih Chu
Chishih Chu
SUMMARY: NontyphoidSalmonellastrains are important causes of reportable food-borne infection. Among more than 2,000 serotypes,Salmonella entericaserotype Choleraesuis shows the highest predilection to cause systemic infections in humans. The most feared complication of serotype Cholearesuis bacteremia in adults is the development of mycotic aneurysm, which previously was almost uniformally fatal. The advances in diagnostic techniques, surgical care, and antimicrobial therapy have greatly improved the survival of these patients. However, the recent emergence of serotype Choleraesuis that is resistant to ampicillin, chloramphenicol, trimethoprim-sulfamethoxazole, and, notably, fluoroquinolone antibiotics has aroused concern about the use of these agents for the empirical treatment of systemic infection caused by this organism. In view of the serious implications of the situation, the chain of transmission and mechanism of resistance should be carefully studied to reduce the spread of infection and threat to human health. To date, there are no vaccines available to prevent serotype Choleraesuis infections in humans. The availability, in the near future, of the genome sequence of serotype Cholearesuis will facilitate the development of effective vaccines as well as the discovery of new targets for novel antimicrobial agents.

7 February 2002 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
Cheng-Hsun ChiuCheng-Hsun Chiu
Cheng-Hsun Chiu
TWTsu-Lan Wu
Tsu-Lan Wu
LSLin-Hui Su
Lin-Hui Su
CCChishih Chu
Chishih Chu
JCJu-Hsin Chia
Ju-Hsin Chia
TLTzou-Yien Lin
Tzou-Yien Lin
Serotype choleraesuis is a cause of serious systemic infections. Because fluoroquinolones are the drug of choice for the treatment of severe salmonella infections, the emergence and dissemination of fluoroquinolone-resistant S. enterica serotype choleraesuis have clinical consequences. In Taiwan, a hospital-based surveillance system has been in place since 1987 to monitor the incidence of S. enterica serotype choleraesuis infections and the antimicrobial susceptibility of the isolates. We investigated the rapid emergence of fluoroquinolone resistance in this serotype in 2000 and 2001. Pigs in Taiwan were evaluated as a potential source of the resistant salmonella. A total of 501 clinical isolates of S. enterica serotype choleraesuis were recovered in our hospital from 1987 through 2000. The proportion of total salmonella isolates made up by S. enterica serotype choleraesuis decreased from an average of 8.4 percent before 1995 to 2.7 percent in 1996 through 1998. During 1999 and 2000, this proportion increased significantly, to an average of 5.0 percent. Ciprofloxacin resistance in S. enterica serotype choleraesuis has been observed since 2000. In the third quarter of 2001, 60 percent of isolates were resistant to ciprofloxacin. Molecular typing indicated that the primary source of S. enterica serotype choleraesuis isolates was herds of swine. All the resistant isolates from humans and swine had mutations that led to the substitution of phenylalanine for serine at position 83 and asparagine for aspartic acid at position 87 in the gene for DNA gyrase A. This investigation in Taiwan indicates that fluoroquinolone-resistant S. enterica serotype choleraesuis can spread from swine to humans. The use of fluoroquinolones in food animals should be prohibited.

1 January 2005 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
Cheng-Hsun ChiuCheng-Hsun Chiu
Cheng-Hsun Chiu
Petrus TangPetrus Tang
Petrus Tang
CCChishih Chu
Chishih Chu
SHSongnian Hu
Songnian Hu
QBQiyu Bao
Qiyu Bao
YLYing-Shiung Lee
Ying-Shiung Lee
Salmonella enterica serovar Choleraesuis (S.Choleraesuis), a highly invasive serovar among non-typhoidal Salmonella, usually causes sepsis or extra-intestinal focal infections in humans. S.Choleraesuis infections have now become particularly difficult to treat because of the emergence of resistance to multiple antimicrobial agents. The 4.7 Mb genome sequence of a multidrug-resistant S.Choleraesuis strain SC-B67 was determined. Genome wide comparison of three sequenced Salmonella genomes revealed that more deletion events occurred in S.Choleraesuis SC-B67 and S.Typhi CT18 relative to S.Typhimurium LT2. S.Choleraesuis has 151 pseudogenes, which, among the three Salmonella genomes, include the highest percentage of pseudogenes arising from the genes involved in bacterial chemotaxis signal-transduction pathways. Mutations in these genes may increase smooth swimming of the bacteria, potentially allowing more effective interactions with and invasion of host cells to occur. A key regulatory gene of TetR/AcrR family, acrR, was inactivated through the introduction of an internal stop codon resulting in overexpression of AcrAB that appears to be associated with ciprofloxacin resistance. While lateral gene transfer providing basic functions to allow niche expansion in the host and environment is maintained during the evolution of different serovars of Salmonella, genes providing little overall selective benefit may be lost rapidly. Our findings suggest that the formation of pseudogenes may provide a simple evolutionary pathway that complements gene acquisition to enhance virulence and antimicrobial resistance in S.Choleraesuis.